Brochure | January 24, 2023

Turbocharge Your Vaccine Development

Worker Holding Vaccine Vial GettyImages-1403976499

The industry’s response to COVID-19 has made it clear that vaccines made right – meaning “safe, efficacious and readily available” – will find a market, whether or not they’re in the headlines.

We’re not looking to introduce incremental change; instead, our modular approach to next-generation vaccine manufacturing is designed to integrate novel biological, analytical or process-related technologies that can leapfrog the industry forward.

As your clinical and commercial supply partner in vaccine discovery and development, we will be teaming you up with our experts in live viruses, viral vectors, oncolytic viruses and vectors, potency assays and virus-like particles (VLP) and antigen vaccines. Our capabilities extend to our industry-leading expression systems, which are already proving their mettle in vaccines directed at public health threats.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma